NCT05294250View on ClinicalTrials.gov

Study of the Effect of Food Intake on the Bioavailability of XC8 10 mg Film-coated Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

February 3, 2022

Study Completion Date

February 26, 2022

Conditions
Healthy
Interventions
DRUG

XC8

XC8 10 mg film-coated tablets, 3 discrete doses of 20 mg each separated by 7-day wash-out periods

Trial Locations (1)

196143

"Limited Liability Company Research Center Eco-Security", Saint Petersburg

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY